Antibiotic-specific practices by individual medicine and SP case presentation
| Overall | Case 1 | Case 2 | Case 3 | |||||
| N | % (95% CI) | N | % (95% CI) | N | % (95% CI) | N | % (95% CI) | |
| Any antibiotic | 435 | – | 201 | – | 91 | – | 143 | – |
| AWaRE classification | ||||||||
| Access | 374 | 86.1 (82.9 to 88.5) | 174 | 87.6 (83.0 to 91.0) | 76 | 83.5 (76.4 to 88.8) | 121 | 85.3 (77.0 to 91.0) |
| Watch | 56 | 12.8 (10.2 to 16.0) | 24 | 12.1 (8.8 to 16.0) | 11 | 12.1 (7.3 to 19.3) | 21 | 14.7 (9.0 to 23.0)) |
| Reserve | 0 | – | 0 | – | 0 | – | 0 | – |
| Discouraged* | 1 | 0.2 (0.0 to 2.0) | 1 | 0.5 (0.1 to 1.8) | 0 | – | 0 | – |
| Other† | 4 | 0.9 (0.3 to 2.4) | 0 | – | 4 | 4.4 (1.3 to 14.0) | 0 | – |
| ATC classification | ||||||||
| Penicillin | 275 | 63.2 (58.7 to 67.5) | 138 | 68.7 (61.6 to 75.0) | 50 | 54.9 (45.8 to 63.8) | 87 | 60.8 (52.8 to 68.3) |
| Sulfonamide‡ | 59 | 13.6 (10.7 to 17.0) | 23 | 11.4 (8.6 to 15.0) | 11 | 12.1 (6.9 to 20.2) | 25 | 17.5 (12.2 to 24.4) |
| Fluoroquinolone | 38 | 8.8 (6.3 to 12.3) | 15 | 7.5 (4.2 to 13.1) | 7 | 7.8 (4.1 to 14.2) | 16 | 11.3 (7.2 to 17.2) |
| Tetracycline | 26 | 6.0 (4.6 to 7.8) | 9 | 4.5 (2.3 to 8.6) | 10 | 11.0 (6.5 to 17.9) | 7 | 4.9 (2.3 to 9.9) |
| Macrolide | 16 | 3.7 (2.5 to 5.5) | 7 | 3.5 (1.5 to 8.0) | 4 | 4.4 (1.6 to 11.9) | 5 | 3.5 (1.5 to 7.8) |
| Cephalosporin | 10 | 2.3 (1.1 to 4.7) | 6 | 3.0 (1.5 to 6.1) | 3 | 3.3 (1.5 to 7.2) | 1 | 0.7 (0.1 to 4.4) |
| Imidazole§ | 6 | 1.4 (0.6 to 3.3) | 2 | 1.0 (0.3 to 3.3) | 2 | 2.2 (0.4 to 11.0) | 2 | 1.4 (0.4 to 5.5) |
| Antimycobacterial | 3 | 0.7 (0.2 to 2.2) | 0 | – | 3 | 3.3 (1.7 to 9.1) | 0 | – |
| Combinations*¶ | 1 | 0.2 (0.0 to 1.5) | 1 | 0.5 (0.2 to 1.6) | 0 | – | 0 | – |
| Unknown | 1 | 0.2 (0.0 to 1.8) | 0 | – | 1 | 1.1 (0.3 to 3.7) | 0 | – |
*Amoxicillin/flucloxacillin fixed-dose combination.
†Anti-TB treatment (n=3), unknown antibiotic (n=1).
‡Sulfamethoxazole/trimethoprim (co-trimoxazole).
§Metronidazole.
¶Does not include antimycobacterial combinations.
ATC, Anatomical Therapeutic Chemical; AWaRE, Access, Watch and Reserve; SP, standardised patients; TB, tuberculosis.